Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CRISPR Therapeutics AG | Chief Financial Officer | Common Shares | 6.48K | $471K | $72.69 | Mar 15, 2024 | Direct |
CRISPR Therapeutics AG | Chief Financial Officer | Stock Option (Right to Buy) | 36.2K | Mar 20, 2024 | Direct | ||
CRISPR Therapeutics AG | Chief Financial Officer | Restricted Stock Units | 25K | Mar 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRSP | CRISPR Therapeutics AG | Mar 20, 2024 | 2 | $0 | 4 | Mar 22, 2024 | Chief Financial Officer |
CRSP | CRISPR Therapeutics AG | Mar 14, 2024 | 3 | -$256K | 4 | Mar 18, 2024 | Chief Financial Officer |
CRSP | CRISPR Therapeutics AG | Oct 13, 2023 | 1 | $0 | 4 | Oct 17, 2023 | Chief Financial Officer |
CRSP | CRISPR Therapeutics AG | Mar 14, 2023 | 2 | $0 | 4 | Mar 14, 2023 | Chief Financial Officer |
CRSP | CRISPR Therapeutics AG | Mar 14, 2023 | 0 | $0 | 3 | Mar 14, 2023 | Chief Financial Officer |